Inspired? If you’re an Early Career Researcher you could win a £500 grant to share your research at an academic conference. Next deadline is 28th February 2018
The dysfunction of cells' energy generators - the mitochondria - plays a key role in multiple sclerosis and offers new ways of treatment.
Mounting evidence points to a link between the make-up of the gut microbiome and multiple sclerosis (MS). Tweaking our bacterial mix can pave the way for new therapies.
Antibodies are a new alternative to anti-inflammatory drugs for curbing the progress of MS and letting patients enjoy their lives. They work by neutralising the ‘misguided’ immune cells associated with the disease.